Jason Wittes
Stock Analyst at Roth Capital
(3.28)
# 1,075
Out of 5,042 analysts
61
Total ratings
49.06%
Success rate
3.86%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $9.11 | +339.08% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $381.79 | +19.44% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $1.95 | +720.51% | 2 | Mar 21, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $2.51 | +537.45% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $15.97 | +37.76% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $78.52 | -8.30% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.12 | +114.84% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $62.29 | +84.62% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $12.38 | +190.79% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.46 | +47.45% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.19 | +740.34% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $89.21 | +12.10% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.09 | +61.81% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.57 | +473.25% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $32.87 | +128.17% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $16.11 | +36.56% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $103.03 | +16.47% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $147.78 | +39.40% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $184.82 | -21.55% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $16.83 | -10.85% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $13.75 | +1,354.55% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $33.34 | -22.00% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $9.11
Upside: +339.08%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $381.79
Upside: +19.44%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.95
Upside: +720.51%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $2.51
Upside: +537.45%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.97
Upside: +37.76%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $78.52
Upside: -8.30%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.12
Upside: +114.84%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $62.29
Upside: +84.62%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.38
Upside: +190.79%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.46
Upside: +47.45%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $89.21
Upside: +12.10%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $3.09
Upside: +61.81%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.57
Upside: +473.25%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $32.87
Upside: +128.17%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $16.11
Upside: +36.56%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $103.03
Upside: +16.47%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $147.78
Upside: +39.40%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $184.82
Upside: -21.55%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $16.83
Upside: -10.85%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $13.75
Upside: +1,354.55%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $33.34
Upside: -22.00%